 |
English thesaurus - terms added by user BB50: 49
| 18.02.2024 | 16:25:20 | abbr. med. | HGC | high glucose concentration |
| 16.02.2024 | 21:21:31 | abbr. med. | ALIOS | American lifestyle-induced obesity syndrome (В экспериментах на животных (грызунах) применяется ALIOS-диета: ALIOS diet is a modified high-fat diet in which 45% of the caloric content is derived from fat; 30% of the fat is present in the form of partially hydrogenated vegetable oil, consisting of 28% saturated, 57% monounsaturated, and 13% polyunsaturated fatty acids.) |
| 15.02.2024 | 14:05:22 | med. | vHP | ventral hippocampus |
| 15.02.2024 | 10:09:44 | abbr. med. | VTA | ventral tegmental area |
| 14.02.2024 | 19:28:29 | abbr. | CeA | central nucleus of the amygdala |
| 14.02.2024 | 19:25:10 | abbr. med. | IPBN | interpeduncular nucleus (межножковое ядро) |
| 12.02.2024 | 13:59:10 | abbr. med. | ERP | European Reference Product (Европейский референтный препарат) |
| 10.07.2021 | 12:08:55 | abbr. pharma. | MFS | midwall fractional shortening |
| 10.04.2021 | 16:28:40 | abbr. pharma. | SIRC | Society for Implementation Research Collaboration |
| 3.03.2021 | 13:12:56 | abbr. pharma. | ACD | компания Advanced Chemistry Development Inc., Канада |
| 22.02.2021 | 8:29:18 | abbr. pharma. | SPIL | Sun Pharmaceutical Industries Ltd |
| 18.02.2021 | 20:18:42 | abbr. India | MCC | Medical Counseling Committee |
| 27.09.2020 | 9:27:42 | abbr. pharma. | SCF | Scientific Committee on Food (Научный комитет по пищевым продуктам) |
| 5.08.2020 | 18:21:45 | med. | CMD h | Co-ordination group for Mutual recognition and Decentralised procedures – human (Координационная группа по взаимному признанию (регистрации) и децентрализованным процедурам (относится к лекарственным препаратам для клинического применения)) |
| 5.08.2020 | 18:18:21 | abbr. med. | CMDh | Co-ordination group for Mutual recognition and Decentralised procedures – human (Координационная группа по взаимному признанию (регистрации) и децентрализованным процедурам (относится к препаратам для клинического применения)) |
| 30.01.2020 | 15:09:24 | abbr. med. | REACH | REduction of Atherothrombosis for Continued Health |
| 10.11.2019 | 14:41:11 | abbr. pharma. | SDR | Signal of Disproportionate Reporting (Сигнал непропорциональности сообщений (о нежелательных сообщениях в связи с конкретным препаратом в PSUR)) |
| 28.06.2019 | 14:17:57 | gen. | MD | maintenance dose (поддерживающая доза) |
| 20.06.2019 | 18:16:38 | abbr. med. | ACP | Autologous Conditioned Plasma |
| 9.05.2019 | 11:22:21 | abbr. med. | AESPID | Sponsor-defined identifier of adverse events |
| 1.05.2019 | 16:56:16 | abbr. med. | SSQ | Standardised Search Query |
| 1.05.2019 | 16:56:16 | abbr. med. | Standardised Search Query | SSQ |
| 2.04.2019 | 9:18:11 | abbr. med. | PI | proteasome inhibitor - ингибитор протеасом |
| 2.04.2019 | 9:16:42 | abbr. oncol. | PI | proteasome inhibitor-ингибитор протеасом |
| 1.04.2019 | 19:18:01 | abbr. oncol. | SPM | Second Primary Malignancy |
| 1.04.2019 | 19:16:52 | abbr. oncol. | Second Primary Malignancy | SPM |
| 8.03.2019 | 12:11:39 | abbr. med. | PCM | plasma cell malignancy |
| 6.03.2019 | 10:10:15 | abbr. med. | MSC | mesenchymal stromal cells |
| 4.09.2018 | 11:35:14 | abbr. oncol. | ED-SCLC | Extensive-Disease Small Cell Lung Cancer |
| 4.09.2018 | 11:35:14 | abbr. oncol. | Extensive-Disease Small Cell Lung Cancer | ED-SCLC |
| 30.07.2018 | 18:08:06 | pharma. | cpv | continued process verification |
| 30.07.2018 | 18:08:06 | abbr. pharma. | continued process verification | cpv |
| 24.07.2018 | 18:46:55 | abbr. pharma. | EQMP | Environmental Quality Management Plan |
| 24.07.2018 | 18:46:55 | abbr. pharma. | Environmental Quality Management Plan | EQMP |
| 27.04.2018 | 17:58:47 | abbr. med. | JRS | Japan Respiratory Society (японское общество специалистов по дыхательной системе) |
| 27.04.2018 | 17:57:06 | abbr. med. | Japan Respiratory Society | JRS (японское общество специалистов по дыхательной системе) |
| 26.04.2018 | 11:51:49 | abbr. pulm. | TBH | Turbuhaler® (Турбухалер® (многодозовый ингалятор компании АстраЗенека, позволяющий дозировать и вдыхать лекарственный препарат в виде порошка. Когда пациент делает вдох, порошок из Турбухалера® доставляется в легкие.)) |
| 3.04.2018 | 8:38:28 | abbr. pharma. | BSC | biological safety cabinet |
| 15.02.2018 | 8:59:30 | gen. | sig | significance |
| 5.02.2018 | 19:44:02 | abbr. cardiol. | TMF | transmitral flow (трансмитральный (через митральный клапан сердца) кровоток) |
| 20.10.2017 | 9:02:50 | abbr. med. | MSAP | Medical Safety Assessment Physician |
| 20.10.2017 | 9:02:50 | abbr. med. | Medical Safety Assessment Physician | MSAP |
| 25.06.2017 | 18:19:47 | abbr. clin.trial. | PACQLQ | Pediatric Asthma Caregiver’s Quality of Life Questionnaire |
| 25.06.2017 | 17:59:46 | abbr. clin.trial. | PAQLQ | Pediatric Asthma Quality of Life Questionnaire |
| 30.11.2016 | 10:41:19 | abbr. pharma. | RPD | recognition-primed decision in risk management theory |
| 6.12.2015 | 21:06:06 | abbr. med. | darc | Digital Angiography Reading Center |
| 6.12.2015 | 21:06:06 | abbr. med. | Digital Angiography Reading Center | DARC |
| 21.12.2014 | 16:03:12 | abbr. perf. | Licensing Standards of Cosmetics | CLS (Стандарты лицензирования косметических средств Японии) |
| 4.12.2014 | 17:28:20 | abbr. med. | AUD | the area under the curve for the concentration-versus-time profile up to the last quantifiable datum point |